1. Home
  2. JXN vs HALO Comparison

JXN vs HALO Comparison

Compare JXN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JXN
  • HALO
  • Stock Information
  • Founded
  • JXN 1961
  • HALO 1998
  • Country
  • JXN United States
  • HALO United States
  • Employees
  • JXN N/A
  • HALO N/A
  • Industry
  • JXN Life Insurance
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • JXN Finance
  • HALO Health Care
  • Exchange
  • JXN Nasdaq
  • HALO Nasdaq
  • Market Cap
  • JXN 5.6B
  • HALO 7.4B
  • IPO Year
  • JXN N/A
  • HALO N/A
  • Fundamental
  • Price
  • JXN $84.37
  • HALO $65.87
  • Analyst Decision
  • JXN Hold
  • HALO Buy
  • Analyst Count
  • JXN 5
  • HALO 9
  • Target Price
  • JXN $91.80
  • HALO $63.78
  • AVG Volume (30 Days)
  • JXN 630.7K
  • HALO 2.0M
  • Earning Date
  • JXN 05-07-2025
  • HALO 05-06-2025
  • Dividend Yield
  • JXN 3.79%
  • HALO N/A
  • EPS Growth
  • JXN N/A
  • HALO 55.40
  • EPS
  • JXN 1.10
  • HALO 3.76
  • Revenue
  • JXN $7,422,000,000.00
  • HALO $1,084,306,000.00
  • Revenue This Year
  • JXN $109.76
  • HALO $20.06
  • Revenue Next Year
  • JXN $0.57
  • HALO $24.20
  • P/E Ratio
  • JXN $76.83
  • HALO $17.56
  • Revenue Growth
  • JXN 110.55
  • HALO 25.64
  • 52 Week Low
  • JXN $64.70
  • HALO $41.28
  • 52 Week High
  • JXN $115.22
  • HALO $70.51
  • Technical
  • Relative Strength Index (RSI)
  • JXN 61.75
  • HALO 58.99
  • Support Level
  • JXN $79.50
  • HALO $58.38
  • Resistance Level
  • JXN $87.60
  • HALO $70.51
  • Average True Range (ATR)
  • JXN 2.45
  • HALO 2.50
  • MACD
  • JXN 1.33
  • HALO 0.88
  • Stochastic Oscillator
  • JXN 80.01
  • HALO 64.61

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

Share on Social Networks: